The Australian Breast Device Registry (ABDR) is a Commonwealth Government health initiative that records information on surgeries involving breast devices, such as breast implants. Managed by Monash University, the ABDR is endorsed by major surgical societies in Australia.
To identify and report on possible trends and complications associated with breast device surgery; to track the long-term safety and performance of implantable breast devices; and to identify best surgical practice and optimal patient health outcomes.
Your information makes an invaluable contribution to the ABDR. We are a long-term project to help safeguard the health of people undergoing breast device surgery. For many patients the ABDR provides peace of mind their device details are recorded. Plus, participation is easy.
29.10.2020 Australia’s device regulator, the Therapeutic Goods Administration (TGA) today announced three breast implant devices that were suspended in May this year pending review, are now cancelled. The authority advised on their website: “Even if your breast implants are being cancelled, suspended or recalled, medical experts do not recommend removing them if you do not have symptoms of BIA-ALCL. This is because BIA-ALCL is very rare, and the risk of undergoing surgery could be higher than the risk of developing BIA-ALCL.” The TGA’s breast implant hub has information to support people with any concerns about their implants, or those considering implants. Additional information regarding the TGA’s safety and performance concerns about the suspended breast implants is also available to assist health professionals in making informed decisions.
8.05.2020 The TGA advised that following a review of breast implant devices, five products have been cancelled while three are suspended from use for a further six months. This action only applies to devices which have not been implanted. The TGA advises on their website: “If you have any of the above breast implants, you do not need to do anything except be aware of the symptoms of BIA-ALCL and seek advice from a health professional if you notice any changes.” Suspended and cancelled devices cannot be supplied, imported or exported from Australia without special authorisation. The TGA’s breast implant hub has information for people with concerns about their implants (or considering implants). Information about BIA-ALCL, a rare form of cancer of the immune system is here.
The ABDR’s work continues during this pandemic. If you are in the registry and need information about your device, please contact our team on (03 9903 0205) or email firstname.lastname@example.org.
TGA information about breast implants and Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare type of cancer of the immune system. It is not breast cancer. The TGA (Australian Therapeutic Goods Administration) has a dedicated breast implant hub with information about ALCL for consumers and information for health professionals. View a summary of announcements, including links to TGA webinars and videos.
Contact the ABDR
1800 998 722